Evidence map›Paper›PMID 35062699›Full record

ArticleVaccines2021

Allergy Associated Myocardial Infarction: A Comprehensive Report of Clinical Presentation, Diagnosis and Management of Kounis Syndrome.

Anastasios Roumeliotis, Periklis Davlouros, Maria Anastasopoulou, Grigorios Tsigkas, Ioanna Koniari, Virginia Mplani, Georgios Hahalis, Nicholas G Kounis

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. From Allergy to Angina: A Unique Presentation of Kounis Syndrome.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Kounis Syndrome: Review of Clinical Cases.Cardiovascular & hematological disorders drug targets · 2024
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Anastasios RoumeliotisDepartment of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA 02138, USA.
Periklis DavlourosDivision of Cardiology, Department of Internal Medicine, Medical School, University of Patras, 26500 Patras, Greece.
Maria AnastasopoulouDivision of Cardiology, Department of Internal Medicine, Medical School, University of Patras, 26500 Patras, Greece.
Grigorios TsigkasDivision of Cardiology, Department of Internal Medicine, Medical School, University of Patras, 26500 Patras, Greece.
Ioanna KoniariManchester Heart Institute, Manchester University Foundation Trust, Manchester M23 9LT, UK.
Virginia MplaniIntensive Care Unit, Medical School, University of Patras, 26500 Patras, Greece.ORCID 0000-0003-1610-0156
Georgios HahalisDivision of Cardiology, Department of Internal Medicine, Medical School, University of Patras, 26500 Patras, Greece.
Nicholas G KounisDivision of Cardiology, Department of Internal Medicine, Medical School, University of Patras, 26500 Patras, Greece.ORCID 0000-0002-9751-6710
University of Patras · GRManchester University NHS Foundation Trust · GBMount Auburn Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kounis syndrome (KS) has been defined as acute coronary syndrome (ACS) in the context of a hypersensitivity reaction. Patients may present with normal coronary arteries (Type I), established coronary artery disease (Type II) or in-stent thrombosis and restenosis (Type III). We searched PubMed until 1 January 2020 for KS case reports. Patients with age <18 years, non-coronary vascular manifestations or without an established diagnosis were excluded. Information regarding patient demographics, medical history, presentation, allergic reaction trigger, angiography, laboratory values and management were extracted from every report. The data were pulled in a combined dataset. From 288 patients with KS, 57.6% had Type I, 24.7% Type II and 6.6% Type III, while 11.1% could not be classified. The mean age was 54.1 years and 70.6% were male. Most presented with a combination of cardiac and allergic symptoms, with medication being the most common trigger. Electrocardiographically, 75.1% had ST segment elevation with only 3.3% demonstrating no abnormalities. Coronary imaging was available in 84.8% of the patients, showing occlusive lesions (32.5%), vascular spasm (16.2%) or normal coronary arteries (51.3%). Revascularization was pursued in 29.4% of the cases. In conclusion, allergic reactions may be complicated by ACS. KS should be considered in the differential diagnosis of myocardial infarction with non-obstructive coronary arteries.

Indexed as

acute coronary syndromeallergyanaphylaxisKounissyndrome

Identifiers

PMID35062699
PMCPMC8781167
OpenAlexW4200511545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.